Julie Lepin
Senior Vice President and Chief Regulatory Affairs Officer
Julie Lepin joined as Senior Vice President and Chief Regulatory Affairs Officer in September 2024.
Mrs. Lepin has held key positions at global companies such as Amgen and Merck, where she served as Vice President of Regulatory Affairs Oncology, as well as at innovative biotechnology startups including Juno, Sana Biotechnology and Mural Oncology.
Mrs. Lepin holds a bachelor’s degree in Biochemistry and Diploma in Ethics and Theology from King’s College London, and a master’s degree in Regulatory Affairs from Cardiff University.
